Minneapolis [US], June 10: A new study published in The LancetInfectious Diseases supported by the Parsemus Foundation found a 41 per cent reduction in Long COVID rates among people who used metformin at the time of COVID infection. The trial also saw a 42 per cent reduction in emergency roo
University of Minnesota researchers discovered that metformin, a medicine typically used to treat diabetes, reduces the development of protracted COVID in a recent study published in The Lancet Infectious Diseases.
In patients with chronic heart failure, remote pulmonary artery pressure monitoring improves the quality of life and lowers the number of heart failure hospitalisations, according to the first investigator-initiated study on the topic. The research was released in The Lancet and was presente
An worldwide study commissioned by the journal Lancet three years ago revealed 12 modifiable risk factors for dementia, including three new ones: excessive alcohol consumption, brain damage, and air pollution.
Three years ago, international research commissioned by the journal Lancet identified 12 modifiable risk factors for dementia, including three new ones: excessive alcohol use, brain injury, and air pollution.
Mumbai (Maharashtra) [India], March 21 (ANI/PRNewswire): Globally, tobacco control measures are not yielding the desired outcomes exacerbating the challenges for policymakers. WHO statistics indicate that 8 million deaths occur every year due to tobacco and an additional 1.2 million deaths a
A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial. The vaccine, developed by researchers at the National Institute of Allergy and Infectious Diseases (NIAID),
According to research published in 'The Lancet Planetary Health', antibiotic residues in wastewater and wastewater treatment plants in the regions surrounding China and India risk contributing to antibiotic resistance, and drinking water may pose a threat to human health.
According to a recent perspective piece published in the Lancet Diabetes & Endocrinology, osteoporosis screening and treatment lags behind other diseases, resulting in significant morbidity, death, and economic implications.
Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab--a novel, patient-tailored monoclonal antibody therapy--showed promising results both while taking the drug and up to 20 weeks after the therapy was stopped, Mount Sinai researchers report
Individuals with a history of hospitalisation for substance use disorders had considerably worse results following the onset of a wide range of physical health illnesses, according to experts from the UK and Czechia.